Quarterly report pursuant to Section 13 or 15(d)

FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - Merger (Details Textual)

v2.4.0.8
FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - Merger (Details Textual) (USD $)
1 Months Ended
Jul. 31, 2013
Merger [Member]
 
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 9,000,000
Aggregate Common Stock Holding Percentage 28.50%
Warrants Issued For Purchase Of Common Stock 1,000,000
Investment Warrants, Exercise Price $ 2.00
Herbert Conrad [Member]
 
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 351,563
Warrants Issued For Purchase Of Common Stock 250,000
Roelof Rongen [Member]
 
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 3,417,186
Abdel A Fawzy [Member]
 
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 1,708,593
George Bobotas And His Spouse [Member]
 
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 1,366,875
Jerome Jabbour [Member]
 
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 759,374
Stefano Ferrari [Member]
 
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 351,563
Warrants Issued For Purchase Of Common Stock 250,000